Lataa...
Low-density lipoprotein cholesterol lowering treatment: the current approach
In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase inhibitor...
Tallennettuna:
| Julkaisussa: | Lipids Health Dis |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201678/ https://ncbi.nlm.nih.gov/pubmed/32375792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-020-01275-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|